Apr 15 |
Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M
|
Apr 15 |
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
|
Apr 11 |
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
|
Mar 26 |
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
|
Feb 21 |
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
|
Feb 20 |
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
|
Feb 16 |
Novo Integrated Sciences Appoints New President
|
Jan 22 |
Novo Integrated Sciences GAAP EPS of -$0.28, revenue of $3.89M
|
Jan 22 |
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
|
Dec 19 |
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
|